Richard D. Francis
President, CEO & DirectorMr. Richard D. Francis is Non-Executive Director of Purespring Therapeutics Limited. He serves as President and Chief Executive Officer at Teva Pharmaceutical Industries Limited since January 01, 2022 and serves as its Director. Mr. Francis served as Division Head and Chief Executive Officer of Sandoz International GmbH and Sandoz Canada Inc. since May 01, 2014 until March 2019. He served as Division Head of Sandoz at Novartis AG since May 01, 2014. Mr. Francis joined Sandoz from Biogen Idec, where he held global and country leadership positions over his career with the company. He served as the President and General Manager at Biogen Idec Canada Inc. He joined Novartis from Biogen Idec, where he held global and country leadership positions over his career with the company. He served as the Senior Vice President and General Manager of Biogen Idec’s US Commercial organization. In that role, Mr. Francis led several successful launches, including that of Tecfidera, Tysabri and the Avonex pen and titration devices, all important advances in the treatment of multiple sclerosis. From 1998 to 2001, he was at Sanofi in the United Kingdom, where he held various marketing roles across the company’s urology, analgesics and cardiovascular products. He has also held sales and marketing positions at Lorex Synthelabo and Wyeth. He also served as a Member of the Board of Directors at BIOTECanada. Mr. Francis holds a BA in Economics from the Manchester Metropolitan University, England. He spends part of his time as a Partner at Syncona Investment Management Limited. He is a Director of Purespring Therapeutics, a kidney focused AAV gene therapy company, since January 2023. From February 2021 until December 2022, Mr. Francis was Chief Executive Officer of Purespring Therapeutics. He was Independent Director of Mettler-Toledo International Inc. from May 2016 to August 2025.
Positions
- Company NameTeva Pharmaceutical Industries LimitedStock CodeTEVAPositionPresident, CEO & DirectorColleagues
- SJSol J. BarerIndependent Chairman of the Board
- ESEliyahu Sharon KalifExecutive VP & CFO
- CFChristine FoxExecutive VP of US Commercial & Head of Innovative Franchise
- ELEvan LippmanExecutive Vice President of Business Development
- MSMatthew ShieldsExecutive Vice President of Global Operations
- RARosemary A. CraneIndependent Director
- GMGerald M. LiebermanIndependent Director
- RARoberto Agostino MignoneIndependent Director
